Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1995 Mar;95(3):1151–1157. doi: 10.1172/JCI117763

Atrial and brain natriuretic peptides stimulate the production and secretion of C-type natriuretic peptide from bovine aortic endothelial cells.

B Nazario 1, R M Hu 1, A Pedram 1, B Prins 1, E R Levin 1
PMCID: PMC441452  PMID: 7883964

Abstract

C-type natriuretic peptide (CNP) is a member of the natriuretic peptide family which is produced in vascular endothelial cells and may play an important paracrine role in the vasaculature. We sought to determine the regulation of CNP production by other vasoactive peptides from cultured aortic endothelial cells. The vasoconstrictors endothelin-1 and angiotensin II had little effect on the basal secretion of CNP. In contrast, atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) strongly stimulated the secretion of CNP. BNP caused as much as a 400-fold enhancement above the basal accumulated secretion of CNP over 24 h at a concentration of 1 microM; this was 20 times greater than the stimulatory effect of ANP, BNP and ANP also significantly enhanced the production of new CNP protein (translation) and mRNA expressed in the BAEC. In contrast, C-ANP-4-23, a truncated form of ANP which selectively binds to the natriuretic peptide clearance receptor, did not stimulate CNP secretion. The enhanced production and secretion of CNP, caused by either ANP or BNP, was significantly prevented by LY 83583, an inhibitor of cGMP generation, and was also attenuated by KT 5823, an inhibitor of cGMP-dependent protein kinase. Our results indicate that ANP and BNP can stimulate CNP production through a guanylate cyclase receptor on endothelial cells. BNP is a much more potent stimulator of CNP secretion, compared to ANP. Our findings suggest that the vasodilatory, and anti-mitogenic effects of ANP and BNP in the vasculature could occur in part through CNP production and subsequent action if these interactions occur in vivo.

Full text

PDF
1151

Images in this article

1154Image
on p.1154
1155Image
on p.1155

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Appel R. G. Growth-regulatory properties of atrial natriuretic factor. Am J Physiol. 1992 Jun;262(6 Pt 2):F911–F918. doi: 10.1152/ajprenal.1992.262.6.F911. [DOI] [PubMed] [Google Scholar]
  2. Charles C. J., Richards A. M., Espiner E. A. Central C-type natriuretic peptide but not atrial natriuretic factor lowers blood pressure and adrenocortical secretion in normal conscious sheep. Endocrinology. 1992 Oct;131(4):1721–1726. doi: 10.1210/endo.131.4.1396317. [DOI] [PubMed] [Google Scholar]
  3. Clavell A. L., Stingo A. J., Wei C. M., Heublein D. M., Burnett J. C., Jr C-type natriuretic peptide: a selective cardiovascular peptide. Am J Physiol. 1993 Feb;264(2 Pt 2):R290–R295. doi: 10.1152/ajpregu.1993.264.2.R290. [DOI] [PubMed] [Google Scholar]
  4. Furuya M., Aisaka K., Miyazaki T., Honbou N., Kawashima K., Ohno T., Tanaka S., Minamino N., Kangawa K., Matsuo H. C-type natriuretic peptide inhibits intimal thickening after vascular injury. Biochem Biophys Res Commun. 1993 May 28;193(1):248–253. doi: 10.1006/bbrc.1993.1616. [DOI] [PubMed] [Google Scholar]
  5. Furuya M., Ohnuma N., Takehisa M., Hayashi Y., Ishihara T., Minamino N., Kangawa K., Matsuo H. Pharmacological activities of brain natriuretic peptides of human, porcine and rat origin. Eur J Pharmacol. 1991 Aug 6;200(2-3):233–237. doi: 10.1016/0014-2999(91)90577-d. [DOI] [PubMed] [Google Scholar]
  6. Furuya M., Takehisa M., Minamitake Y., Kitajima Y., Hayashi Y., Ohnuma N., Ishihara T., Minamino N., Kangawa K., Matsuo H. Novel natriuretic peptide, CNP, potently stimulates cyclic GMP production in rat cultured vascular smooth muscle cells. Biochem Biophys Res Commun. 1990 Jul 16;170(1):201–208. doi: 10.1016/0006-291x(90)91260-y. [DOI] [PubMed] [Google Scholar]
  7. Hagiwara H., Sakaguchi H., Itakura M., Yoshimoto T., Furuya M., Tanaka S., Hirose S. Autocrine regulation of rat chondrocyte proliferation by natriuretic peptide C and its receptor, natriuretic peptide receptor-B. J Biol Chem. 1994 Apr 8;269(14):10729–10733. [PubMed] [Google Scholar]
  8. Hama N., Itoh H., Shirakami G., Suga S., Komatsu Y., Yoshimasa T., Tanaka I., Mori K., Nakao K. Detection of C-type natriuretic peptide in human circulation and marked increase of plasma CNP level in septic shock patients. Biochem Biophys Res Commun. 1994 Feb 15;198(3):1177–1182. doi: 10.1006/bbrc.1994.1166. [DOI] [PubMed] [Google Scholar]
  9. Hu R. M., Chuang M. Y., Prins B., Kashyap M. L., Frank H. J., Pedram A., Levin E. R. High density lipoproteins stimulate the production and secretion of endothelin-1 from cultured bovine aortic endothelial cells. J Clin Invest. 1994 Mar;93(3):1056–1062. doi: 10.1172/JCI117055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hu R. M., Levin E. R., Pedram A., Frank H. J. Atrial natriuretic peptide inhibits the production and secretion of endothelin from cultured endothelial cells. Mediation through the C receptor. J Biol Chem. 1992 Aug 25;267(24):17384–17389. [PubMed] [Google Scholar]
  11. Kangawa K., Matsuo H. Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP). Biochem Biophys Res Commun. 1984 Jan 13;118(1):131–139. doi: 10.1016/0006-291x(84)91077-5. [DOI] [PubMed] [Google Scholar]
  12. Kase H., Iwahashi K., Nakanishi S., Matsuda Y., Yamada K., Takahashi M., Murakata C., Sato A., Kaneko M. K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem Biophys Res Commun. 1987 Jan 30;142(2):436–440. doi: 10.1016/0006-291x(87)90293-2. [DOI] [PubMed] [Google Scholar]
  13. Khurana M. L., Pandey K. N. Receptor-mediated stimulatory effect of atrial natriuretic factor, brain natriuretic peptide, and C-type natriuretic peptide on testosterone production in purified mouse Leydig cells: activation of cholesterol side-chain cleavage enzyme. Endocrinology. 1993 Nov;133(5):2141–2149. doi: 10.1210/endo.133.5.8404664. [DOI] [PubMed] [Google Scholar]
  14. Kohno M., Horio T., Yokokawa K., Kurihara N., Takeda T. C-type natriuretic peptide inhibits thrombin- and angiotensin II-stimulated endothelin release via cyclic guanosine 3',5'-monophosphate. Hypertension. 1992 Apr;19(4):320–325. doi: 10.1161/01.hyp.19.4.320. [DOI] [PubMed] [Google Scholar]
  15. Maack T., Suzuki M., Almeida F. A., Nussenzveig D., Scarborough R. M., McEnroe G. A., Lewicki J. A. Physiological role of silent receptors of atrial natriuretic factor. Science. 1987 Oct 30;238(4827):675–678. doi: 10.1126/science.2823385. [DOI] [PubMed] [Google Scholar]
  16. O'Donnell M. E., Owen N. E. Role of cyclic GMP in atrial natriuretic factor stimulation of Na+,K+,Cl- cotransport in vascular smooth muscle cells. J Biol Chem. 1986 Nov 25;261(33):15461–15466. [PubMed] [Google Scholar]
  17. Porter J. G., Catalano R., McEnroe G., Lewicki J. A., Protter A. A. C-type natriuretic peptide inhibits growth factor-dependent DNA synthesis in smooth muscle cells. Am J Physiol. 1992 Nov;263(5 Pt 1):C1001–C1006. doi: 10.1152/ajpcell.1992.263.5.C1001. [DOI] [PubMed] [Google Scholar]
  18. Stingo A. J., Clavell A. L., Aarhus L. L., Burnett J. C., Jr Cardiovascular and renal actions of C-type natriuretic peptide. Am J Physiol. 1992 Jan;262(1 Pt 2):H308–H312. doi: 10.1152/ajpheart.1992.262.1.H308. [DOI] [PubMed] [Google Scholar]
  19. Stingo A. J., Clavell A. L., Heublein D. M., Wei C. M., Pittelkow M. R., Burnett J. C., Jr Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma. Am J Physiol. 1992 Oct;263(4 Pt 2):H1318–H1321. doi: 10.1152/ajpheart.1992.263.4.H1318. [DOI] [PubMed] [Google Scholar]
  20. Sudoh T., Kangawa K., Minamino N., Matsuo H. A new natriuretic peptide in porcine brain. Nature. 1988 Mar 3;332(6159):78–81. doi: 10.1038/332078a0. [DOI] [PubMed] [Google Scholar]
  21. Sudoh T., Minamino N., Kangawa K., Matsuo H. C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun. 1990 Apr 30;168(2):863–870. doi: 10.1016/0006-291x(90)92401-k. [DOI] [PubMed] [Google Scholar]
  22. Suga S., Itoh H., Komatsu Y., Ogawa Y., Hama N., Yoshimasa T., Nakao K. Cytokine-induced C-type natriuretic peptide (CNP) secretion from vascular endothelial cells--evidence for CNP as a novel autocrine/paracrine regulator from endothelial cells. Endocrinology. 1993 Dec;133(6):3038–3041. doi: 10.1210/endo.133.6.8243333. [DOI] [PubMed] [Google Scholar]
  23. Suga S., Nakao K., Hosoda K., Mukoyama M., Ogawa Y., Shirakami G., Arai H., Saito Y., Kambayashi Y., Inouye K. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology. 1992 Jan;130(1):229–239. doi: 10.1210/endo.130.1.1309330. [DOI] [PubMed] [Google Scholar]
  24. Suga S., Nakao K., Itoh H., Komatsu Y., Ogawa Y., Hama N., Imura H. Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system". J Clin Invest. 1992 Sep;90(3):1145–1149. doi: 10.1172/JCI115933. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Suga S., Nakao K., Kishimoto I., Hosoda K., Mukoyama M., Arai H., Shirakami G., Ogawa Y., Komatsu Y., Nakagawa O. Phenotype-related alteration in expression of natriuretic peptide receptors in aortic smooth muscle cells. Circ Res. 1992 Jul;71(1):34–39. doi: 10.1161/01.res.71.1.34. [DOI] [PubMed] [Google Scholar]
  26. Suzuki E., Hirata Y., Hayakawa H., Omata M., Kojima M., Kangawa K., Minamino N., Matsuo H. Evidence for C-type natriuretic peptide production in the rat kidney. Biochem Biophys Res Commun. 1993 Apr 30;192(2):532–538. doi: 10.1006/bbrc.1993.1448. [DOI] [PubMed] [Google Scholar]
  27. Tawaragi Y., Fuchimura K., Tanaka S., Minamino N., Kangawa K., Matsuo H. Gene and precursor structures of human C-type natriuretic peptide. Biochem Biophys Res Commun. 1991 Mar 15;175(2):645–651. doi: 10.1016/0006-291x(91)91614-i. [DOI] [PubMed] [Google Scholar]
  28. Wong S. K., Garbers D. L. Receptor guanylyl cyclases. J Clin Invest. 1992 Aug;90(2):299–305. doi: 10.1172/JCI115862. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. de Bold A. J., Borenstein H. B., Veress A. T., Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci. 1981 Jan 5;28(1):89–94. doi: 10.1016/0024-3205(81)90370-2. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES